Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption
A 67-year-old woman with a history of end-stage renal disease on hemodialysis received a therapeutic dose (150 mg daily) of flecainide for three weeks. She was admitted to the Emergency Department for malaise and dizziness, and the electrocardiogram revealed ventricular tachycardia treated by amioda...
Saved in:
Main Authors: | Nicolas De Schryver, Philippe Hantson, Vincent Haufroid, Mélanie Dechamps |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Cardiology |
Online Access: | http://dx.doi.org/10.1155/2019/1905871 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CytoSorb hemoadsorption of apixaban during cardio-pulmonary bypass for heart transplantation
by: Anouk Frering, MD, et al.
Published: (2025-02-01) -
CytoSorb® Hemoadsorption as a Promising Tool to Handle COVID-19-Induced Cytokine Storm
by: Alice-Christin Acevedo, et al.
Published: (2021-01-01) -
To Hemoadsorb or Not to Hemoadsorb—Do We Have the Answer Yet? An Updated Meta-Analysis on the Use of CytoSorb in Sepsis and Septic Shock
by: Carmen Orban, et al.
Published: (2025-01-01) -
Successful Use of Extracorporeal Membrane Oxygenation for the Treatment of Cardiogenic Shock due to Scorpion Envenomation
by: Amine Tarmiz, et al.
Published: (2017-01-01) -
Hemoadsorption in Multiorgan Failure Due to Viscerocutaneous Loxoscelism
by: Raúl Valenzuela Córdova, et al.
Published: (2025-01-01)